Table 1. Baseline characteristics.
| TAC+EVR (%) | TAC+MMF (%) | |
|---|---|---|
| N | 20 | 20 |
| Age | 48.3 (16) | 48.4(13) |
| Gender (% male) | 13 (65) | 16 (80) |
| Race (% Caucasian) | 9 (45) | 13 (65) |
| Pre-emptive transplant | 6 (30) | 7 (35) |
| Cause of ESRD | ||
| Hypertension | 6 (30) | 5 (25) |
| Polycystic kidney disease | 3 (15) | 1 (5) |
| Lupus nephritis | 1 (5) | 1 (5) |
| Other/Unknown | 5 (25) | 5 (25) |
| Diabetics | 5 (25) | 10 (50) |
| Coronary artery disease | 2 (10) | 2 (10) |
| BMI | 24.9 (5) | 28.9(6) |
| PRA- Class I (Mean ± SD) | 1.4 ± 3.1 | 3.3 ± 10.6 |
| PRA- Class II (Mean ± SD) | 2.2 ± 8.3 | 3.8 ± 3.1 |
| Crossmatch | Negative | Negative |
| HLA match | 2 (1) | 2.2(1) |
| Alemtuzumab Induction | 19 (95) | 20 (100) |